M&A Deal Summary |
|
|---|---|
| Date | 2024-08-16 |
| Target | GondolaBio |
| Sector | Life Science |
| Buyer(s) |
Patient Square Capital
BridgeBio |
| Deal Type | Joint Venture |
SEARCH BY
Try For Free 7-Day Free Trial
Patient Square Capital is a private investment firm specializing in the healthcare sector. The Firm seeks opportunities to invest broadly across the healthcare industry, including technology-enabled services, biopharmaceuticals, the pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health. Patient Square Capital was formed in 2020 and is headquartered in Menlo Park, California.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 11 |
| Sector (Life Science) | 3 of 3 |
| Type (Joint Venture) | 1 of 1 |
| State (California) | 2 of 2 |
| Country (United States) | 10 of 11 |
| Year (2024) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-05-10 |
Syneos Health
Morrisville, North Carolina, United States Syneos Health is a fully integrated biopharmaceutical solutions organization built to accelerate customer success. Syneos Health translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Syneos Health was founded in 2010 and is based in Morrisville, North Carolina. |
Buy | $7.1B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-11 |
Patterson Companies
St. Paul, Minnesota, United States Patterson Companies is a specialty distributor serving the dental, veterinary, and rehabilitation supply markets. Patterson's largest business unit is Patterson Dental. The company supplies to dentists, dental laboratories, institutions, and other healthcare professionals. It provides consumable products (including x-ray film, restorative materials, hand instruments, and sterilization products); basic and advanced technology dental equipment; practice management and clinical software; patient education systems; and office forms and stationery. Patterson Companies was founded in 1877 and is based in St. Paul, Minnesota. |
Buy | $4.1B |
| Category | Company |
|---|---|
| Founded | 2015 |
| Sector | Life Science |
| Employees | 550 |
| Revenue | 9M USD (2023) |
BridgeBio is an Orphan disease drug platform with a robust portfolio of transformative drug programs that address rare diseases across oncology, cardiology, dermatology, neurology, and endocrinology. BridgeBio was founded in 2015 and is based in Palo Alto, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Life Science) | 2 of 2 |
| Type (Joint Venture) | 1 of 1 |
| State (California) | 2 of 2 |
| Country (United States) | 2 of 2 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-05 |
Eidos Therapeutics
San Francisco, California, United States Eidos Therapeutics is a biopharmaceutical company developing therapies to treat transthyretin amyloidosis (ATTR), primarily in the heart. Eidos Therapeutics was founded in 2013 and is headquartered in San Francisco, California. |
Buy | - |
